References
1. A.J.Wilcox, C.R.Weinberg, J.F.O' Connor, et al,Incidence of early loss of pregnancy.N Engl J Med, 319(4),pp.189-194, 2000
2. O.B.Christian, R.Steffensen, H.S. Nielsen and K.Varming, Multi-factorial etiology of recurrent miscarriage and its scientific and clinical implications.Gynecol Obstet Invest ,66,pp.257-267, 2008.
3. J.E.Warren, R.M.Silver.Genetics of pregnancy loss.Clin Obstet Gynecol, 51,pp.84-95,2008.
4. M.A.Rodger, M.Paidas, C. Mclin-tock, et al, Inherited thrombophilia and pregnancy complications re-visited. Obstet Gynecol,112, pp.320,2008
5. J.M.Said, J.R.Higgins, E.K.Moses, et al, Inherited thrombophilia polymorphisms in pregnancy outcomes in nulliparous women. Obstet Gynecol,115,pp.5, 2010
6. L.Robertson,O .Wu,P. Langhorne, et al.Thrombophilia in pregnancy; a systematic review.Br J Haematol, 132,pp.171,2006.
7. M.J.Kupfermine.Thrombophilia and pregnancy.Reprod Biol Endocrinol,1,pp.111,2003.
8. D.Dizon-Townson, C. Miller, B.Sibai, et al.The relationship of factor V Leiden mutation and pregnancy outcomes for mother and fetus.Obstet Gynecol,106,pp.517-524,2005.
9. R.M.Silver,Y.Zhao, C.Y. Spong, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol,115, pp.14,2010.
10. M.D.McColl, J.Ellison, F.Reid, et al.Prothrombin 20210G-A, MTHFR C667T mutations in women with venous thromboembolism associated with pregnancy.BJOG,107,pp.565,2000.
11. B.T.Zhu.On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histol Histopathol,17,pp.1283-1291,2002.
12. R.P.Murphy,C. Donoghue, R.J. Nalten, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylene tetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vas Biol, 20,pp.266,2000.
13. C.H.J.Lockwood, K.A.Bauer, L.K.Leung, S.M.Ramin, et al. Inherited thrombophilias in pregnancy.Up To Date , Dec,2015
14. L.Robertson, O.Wu,P. Langhorne, et al.Thrombophilia in pregnancy: a systemic review.Br J Haematol ,132,pp.171,2006.
15. S.Bouvier,E.Cochery-Nouvellon, G.Lavigne-Lissalde, et al. Comparative incidence of pregnancy outcomes in thrombophilia positive women from NOH-APS observational study. Blood,123,pp.414,2014.
16. M.J.Kupfermine.Thrombophilia and pregnancy.Reprod Biol Endocrinol, 1,pp.111,2003
17. A.Rozano-Gorelick, E. Papadakis, B.Brenner. Combined thrombophilia and obstetric complications.Open Athero Thromb J, 2,pp.38-41, 2009.
18. G.Sarig, G.Vidergor, B. Brenner. Assessment and masnagement of high risk pregnancies in women with thrombophilia. Blood Rev,23 (4),pp. 143-147,2009
19. I.A.Greer.The challenge of thrombophilia in maternal-fetal medicine.N Engl J Med ,342,pp.424,2000.
20. M.A.Rodger, M.T.Betancourt, P.Clark, et al.The association of factor V Leiden and prothrombin gene mutation and placenta mediated pregnancy complications: a systemic review and meta analysis of prospective cohort studies. PLOS Med,7(6), pp.e1000292, 2010.
21. H.Roque, M.J.Paidas, E.F. Funai, et al.Maternal thrombophilias are not associated with early pregnancy loss.Thromb Haemost , 91,pp.290,2004.
22. P.Clark, I.D.Walker,L.Govan , et al.The GOAL study: a prospective examination of the impact of factor V Leiden and ABO blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol, 140,pp.236,2008.
23. F.E.Preston, F.R.Rosendaal, I.D.Walker, et al.Increased fetal loss in women with heritable thrombop-hiliaL. Lancet ,348,pp.913,1996.
24. U.Kjellberg, M.Van Rooijen, K. Bremme,M.Hellgren.Factor V Leiden mutation and pregnancy related complications. Am J Obstet Gynecol, 203,pp.469-468,2010.
25. S.Bouvier,E.Cochery-Nouvellon, G.Lavigne-Lissalde, et al. Comparative incidence of pregnancy outcomes in thrombo-philia positive women from NOH-APS observational study. Blood,123,pp.414,2014.
26. P.Di Mico,M.D'Uva.Recurrent pregnancy loss and thrombophilia.Open Atherosclerosis &Thrombosis J,2,pp.33-35,2009.
27. A.Lissak, A.Sharon, O.Fruchter, A.Kassel, et al. Polymorphism for mutation of cytosine to thymine location 677 in the methylene-tetrahydrofolate reductase gene is associated with recurrent early pregnancy loss. Am J Obstet Gynecol, 181,pp.126-130,1999.
28. M.G.Wouters,G.H.Boers, H.J. Blom, F.J.Trijbels, C.M.Thomas, et al.Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss.Fertil Steril,60,pp.820-825,1993.
29. A.Makino, T.Nakanishi, M.Sugiura-Ogasawara ,Y.Ozaki, N.Suzumori, K.Suzumori. No association of C667T methylene-tetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss.Am J Reprod Immunol ,52,pp.60-66,2004.
30. A.Ren, J.Wang. MTHFR C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.Fertil Steril,86,pp.1716,2006.
31. M.Aksoy,I.Tek,H.Karabulut,B.Berker,F.Soylemez.The role of thrombophilia related to factor V and factor II G20210A mutations in recurrent abortions. J Pak Med Assoc ,55,pp.104-108,2005.
32. A.Raziel,Y.Kornberg,S.Friedler, et al.Hypercoaguble thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss.Am J Reprod Immunol,45,pp.65-71,2001.
33. C.B.Coulam,R.S.Jeyendran,A.L.Fishel,R.Roussev.Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage .Am J Reprod Immunol,55,pp.360-380,2006.
34. H.Mandel,B.Brenner,M.Berant.Co-existence of hereditary homocysteinemia and factor V Leiden-effect on thrombosis.N Engl J Med,348,pp.763-768,1996.
35. E.Couto,M.L.Nomura,R.BariniJ.L.Pinto.Silva.Pregnancy associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.Sao Paulo Med J,123(6):pp.286-288,2005.
36. R.B.Zotz, A.Gerhtardt, R.E.Scharf.Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol,16,pp.243,2003.
37. American College of Obstetricians and Gynaecologists Women Health Care Physicians. ACOG Practice Bulletin no 138:Inherited thrombophilias in pregnancy.Obstet Gynecol,122,pp.706-717,2013